Logo Image
Opinion|Videos|April 28, 2025

The Benefits of Lp(a) Testing in the Absence of Lp(a)-Lowering Therapies

Experts discuss how lipoprotein(a) (Lp[a]) testing, even without targeted Lp(a)-lowering therapies, can enhance overall cardiovascular risk assessment and potentially influence the management of other risk factors.

Episodes in this series

Video content above is prompted by the following:

  • Previously, I mentioned the benefits of Lp(a) testing, even in the absence of targeted Lp(a)-lowering therapies. Let’s explore that further. How might Lp(a) testing improve overall cardiovascular risk assessment?
  • How, if at all, might Lp(a) measurement influence the management of other risk factors?

Related Content